Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural determinants of selective thyromimetics.

Hikari A I Yoshihara1, James W Apriletti, John D Baxter

  • 1Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94143-2280, USA.

Journal of Medicinal Chemistry
|June 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does Thyroid Hormone Boost Energy and Plasticity in the Brain as a Mechanism of Action in Antidepressant Augmentation Therapy?

Thyroid : official journal of the American Thyroid Association·2026
Same author

Decoding paradoxical BOLD responses to transcranial ultrasound stimulation with concurrent optoacoustic magnetic resonance imaging.

Science advances·2025
Same author

Transcranial pulse stimulation modulates neuronal activity and functional network dynamics.

Brain stimulation·2025
Same author

Non-invasive large-scale imaging of concurrent neuronal, astrocytic, and hemodynamic activity with hybrid multiplexed fluorescence and magnetic resonance imaging (HyFMRI).

Light, science & applications·2025
Same author

Central thyroid hormone receptor-beta: Sensitivity to alcohol and a role in regulating alcohol drinking.

Hormones and behavior·2025
Same author

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018-2024.

Open forum infectious diseases·2025
Same journal

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same journal

Charting New Territory: Systematic Evaluation of the Drug Potential of <i>N</i>-Trifluoromethyl Amides, Ureas & Carbamates.

Journal of medicinal chemistry·2026
Same journal

Red-Light-Triggered <i>In Vitro</i> and <i>In Vivo</i> Photocatalytic Cancer Therapy with Polypyridyl Os(II) Photocatalysts.

Journal of medicinal chemistry·2026
Same journal

Novel Selenium-Containing Small Molecule PD-L1 Inhibitors: Design, Synthesis, and Evaluation of the Antitumor Activity.

Journal of medicinal chemistry·2026
Same journal

HsClpP-Engaging Selective Mitochondrial Pan-PDK Degraders for Cancer Therapy.

Journal of medicinal chemistry·2026
Same journal

Rational Development of Activatable Prodrugs of the GSTP1 Inhibitor NBDHEX: Turn-On NIR Fluorogenic Drug Delivery with Selective Anticancer Activity.

Journal of medicinal chemistry·2026
See all related articles

The thyromimetic GC-1 selectively binds thyroid hormone receptor beta (TR-beta). Its oxyacetic acid side chain is crucial for this TR-beta selectivity, unlike the less selective DIMIT.

Area of Science:

  • Endocrinology
  • Molecular Pharmacology

Background:

  • Thyroid hormone receptors (TRs) regulate gene expression.
  • TR subtypes (TR-alpha and TR-beta) have distinct physiological roles.
  • Selective TR modulators are valuable research tools and potential therapeutics.

Purpose of the Study:

  • To investigate the structural basis for the selective binding of the thyromimetic GC-1 to TR-beta.
  • To compare the structural features of GC-1 with the less selective analogue DIMIT.
  • To identify key molecular determinants of TR-beta selectivity.

Main Methods:

  • Synthesis of GC-1 and DIMIT analogues with modified structural features.
  • Analysis of binding affinity and selectivity for TR subtypes.
  • Structure-activity relationship studies.

Related Experiment Videos

Main Results:

  • GC-1 exhibits higher affinity and selectivity for TR-beta compared to DIMIT.
  • An analogue of GC-1 with a biaryl ether linkage retained TR-beta selectivity.
  • An analogue of DIMIT with a methylene linkage showed only slight selectivity.
  • The oxyacetic acid side chain of GC-1 was identified as critical for TR-beta selectivity.

Conclusions:

  • The oxyacetic acid side chain is the primary determinant of TR-beta selectivity for GC-1.
  • Structural modifications significantly impact TR subtype binding.
  • Understanding these structure-activity relationships can guide the design of novel TR-selective compounds.